3.431
Intelligent Bio Solutions Inc stock is traded at $3.431, with a volume of 208.13K.
It is up +15.27% in the last 24 hours and up +51.25% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
See More
Previous Close:
$2.77
Open:
$2.86
24h Volume:
208.13K
Relative Volume:
2.07
Market Cap:
$10.36M
Revenue:
$3.91M
Net Income/Loss:
$-11.65M
P/E Ratio:
-0.2785
EPS:
-12.3212
Net Cash Flow:
$-11.51M
1W Performance:
+62.90%
1M Performance:
+51.25%
6M Performance:
-33.62%
1Y Performance:
-78.28%
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INBS
Intelligent Bio Solutions Inc
|
3.4325 | 8.36M | 3.91M | -11.65M | -11.51M | -12.32 |
|
ABT
Abbott Laboratories
|
110.14 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
332.48 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.75 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
51.60 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.85 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions receives ISO 13485:2016 recertification - Investing.com
Intelligent Bio Solutions receives ISO 13485:2016 recertification By Investing.com - Investing.com Canada
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - The Manila Times
A Fingerprint Drug Test Aligns With the FDA's New Regulation—What's Next? - Stock Titan
What Should Readers Watch in Intelligent Bio Solutions (NASDAQ:INBS) as Diagnostic Adoption Comes Into Focus? - kalkinemedia.com
Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Form 8K Intelligent Bio Solutions Inc For: 11 August By Investing.com - Investing.com Canada
Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study - TipRanks
Intelligent Bio Solutions completes multi-site study, targets FDA 510(k) submission in H2 2026 - TradingView
Intelligent Bio Solutions Inc. (INBS) stock price, news, quote and history - Yahoo Finance Singapore
INBS Looks 48.6% Undervalued on GF Value™ but Faces Challenges - GuruFocus
Intelligent Bio Solutions completes FDA clinical study program - Investing.com
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System - The Manila Times
Intelligent Bio Solutions Completes Method Comparison Study for the Intelligent Fingerprinting Drug Screening System - marketscreener.com
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions Inc (INBS) Stock News Today - TradingKey
INBS Q4'26 Earnings: revenue estimate is 1.22M USD - TradingView
Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System Supporting FDA 510(k) Submission - marketscreener.com
Intelligent Bio Solutions Advances Fingerprint Drug Screening Program - TipRanks
Intelligent Bio Solutions completes usability study for FDA filing - Investing.com
Intelligent Bio Solutions Completes Usability Study for Fingerprinting Drug Screen; 510(k) on Track - TradingView
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission - The Manila Times
15 Operators Used Intelligent Bio Solutions' Drug Test Without Lab Training - Stock Titan
Intelligent Bio Solutions Expands Share Count Through Equity Transactions - TipRanks
Intelligent Bio Solutions Advances FDA Path with Interference Study - TipRanks
Intelligent Bio Solutions reports 3,018,188 shares outstanding as of July 31, 2026 - TradingView
Intelligent Bio Solutions Inc. Completes Interference Study for Intelligent Fingerprinting Drug Screening System - marketscreener.com
Intelligent Bio Solutions (INBS) Holds Near $1.82 as Biotech Traders Eye Key ResistanceOvernight Profile - dars.gov.et
INBS|Intelligent Bio Solutions Inc|Price:1.810|Chg%:+0.250 - TradingKey
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: EPS Miss Widens as Revenue Remains Undisclosed - dars.gov.et
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Intelligent Bio Solutions Inc (INBS) Balance Sheet - TradingKey
Free cash flow per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Book value per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Revenue per share of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc (INBS) Institutional Confidence - TradingKey
INBS|Intelligent Bio Solutions Inc|Price:1.750|Chg%:-0.060 - TradingKey
Long term debt to total equity ratio of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Total equity of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Cash flow from financing activities of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Gross profit of Intelligent Bio Solutions Inc. – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc. Income Statement – GETTEX:12Q - TradingView
Intelligent Bio Solutions Inc. (INBS) Q1 2025 Earnings: Wider-than-Expected Loss Weighs on SharesAnalyst Earnings Estimate - dars.gov.et
Intelligent Bio Solutions Inc (INBS) Cash Flow - TradingKey
Intelligent Bio Solutions Inc. Revenue Breakdown – NASDAQ:INBS - TradingView
Intelligent Bio Solutions Resolves Cybersecurity Issues, Prepares FDA 510(k) Submission for U.S. Drug Screening Market Expansion – Minichart - Minichart
Intelligent Bio Solutions Inc (INBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):